Exploring how Immulina boosts the immune system
Official title: Unravelling Immune Enhancement by Immulina
Funded at University of Mississippi · NIH-10897158 · Data updated 2026-11-12
This study is looking at how a compound called Immulina might help boost your immune system, so if you're interested in ways to strengthen your health, this research could provide some helpful insights!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Mississippi NIH-funded |
| Lab location | 1 site (University, United States) |
| Project start | July 1, 2020 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $181,531 |
| NIH project number | 5U19AT010838-05 |
| Project ID | NIH-10897158 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include individuals seeking to improve their immune health or those with compromised immune systems.
✕Less likely to help
Patients with fully functioning immune systems who do not have any underlying health issues may not receive significant benefits from this research.
What this research studies
This research investigates the effects of Immulina, a compound believed to enhance immune function. The study aims to understand the mechanisms through which Immulina operates and its potential applications in improving immune responses. Patients may benefit from insights into how this compound could be used to strengthen their immune systems, particularly in the context of various health conditions. The research employs a combination of laboratory experiments and clinical assessments to evaluate the immune-enhancing properties of Immulina.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing immune function in patients.
How similar studies have gone: While the specific effects of Immulina are being explored in this research, similar immune-enhancing compounds have shown promise in past studies.
Where this research is happening
-
University of Mississippi
University, United States Active
Researchers
- Principal investigator: Tan, Chalet — University of Mississippi
- Study coordinator: Tan, Chalet
Related research
Other NIH-funded projects on the same topics.
-
Science-based authentication, safety, and validation of botanical ingredients
This NIH grant focuses on making sure botanical ingredients used in dietary supplements are authentic, safe, and accurately labeled for consumers.
-
Glycopeptide Nanomaterials That Assemble at Disease Sites Triggered by Oxidative Signals
A new type of tiny, glycan-guided nanomaterial forms right at diseased tissue when exposed to disease-related reactive oxygen species, aiming to deliver drugs more precisely and safely.
-
High-precision glycan detectors using AI to spot disease-linked sugars
A grant to develop AI-guided, highly specific tools that detect disease-related glycans (áGal and NeuGc) in human samples to improve diagnostics and safe biologic therapies.
-
How brevican changes nerve cell excitability in the brain
A small NIH grant is exploring how a brain protein called brevican, and its sugar tags, affect nerve cell activity in a specific brain area tied to fear and stress.
-
Sulfated molecules in the back of the eye and how they shape myopia progression
This grant studies how losing certain building blocks in the eye’s outer layer may affect eye shape and the worsening of nearsightedness in pig eyes to model human disease.
-
Gene networks behind alcohol tolerance in fruit flies
A short, patient-friendly look at how brain signaling related to alcohol tolerance might be reversed or treated.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.